C
Carlos Cabrera López
Researcher at University of Las Palmas de Gran Canaria
Publications - 23
Citations - 375
Carlos Cabrera López is an academic researcher from University of Las Palmas de Gran Canaria. The author has contributed to research in topics: Medicine & COPD. The author has an hindex of 6, co-authored 17 publications receiving 296 citations. Previous affiliations of Carlos Cabrera López include Hospital Universitario Insular de Gran Canaria.
Papers
More filters
Journal ArticleDOI
Defining the Asthma-COPD Overlap Syndrome in a COPD Cohort
Borja G. Cosío,Joan B. Soriano,José Luis López-Campos,Myriam Calle-Rubio,Juan José Soler-Cataluña,Juan P. de-Torres,Jose M. Marin,Cristina Martínez-González,Pilar de Lucas,Isabel Mir,Germán Peces-Barba,Nuria Feu-Collado,Ingrid Solanes,Inmaculada Alfageme,Ciro Casanova,José Calvo Bonachera,Celia Lacárcel Bautista,Adolfo Domenech,Rosirys Guzmán,Rosa Irigaray,Meritxell López Zamora,Ángel Ríos,Rocío Córdova,Carlos Cabrera López,Alejandro Sánchez Acosta,Juan A. Gonzalez,Ramón Agüero Balbin,Eva Balcells,Elena Miguel Campos,Alicia Marin,A. Casanova,Amalia Moreno,Francisca Lourdes Márquez Pérez,Juan Antonio Riesco Miranda,Julia Tabara Rodríguez,Rafael Golpe Gómez,Javier de Miguel Díez,Francisco García Río,Salvador Díaz Lobato,Juan Bautista Galdiz Iturri,Margarita Marín Royo,Alfredo de Diego Damia +41 more
TL;DR: The proposed ACOS criteria are present in 15% of a cohort of patients with COPD and these patients show better 1-year prognosis than clinically similar patientswith COPD with no ACos criteria.
Journal ArticleDOI
Comparison of the 2017 and 2015 Global Initiative for Chronic Obstructive Lung Disease Reports. Impact on Grouping and Outcomes
Carlos Cabrera López,Ciro Casanova Macario,José María Marín Trigo,Juan P. de-Torres,Rebeca Sicilia Torres,Jesús María González,Francesca Polverino,Miguel Divo,Victor Pinto Plata,Javier J. Zulueta,Bartolome R. Celli +10 more
TL;DR: Compared with 2015, the GOLD ABCD 2017 classification significantly shifts patients from grades C and D to categories A and B, making the risk of death similar between them, and the mortality risk was better predicted by the 2015 than the 2017 system.
Journal ArticleDOI
Prevalencia de enfermedad pulmonar obstructiva crónica en las Islas Canarias
Carlos Cabrera López,Gabriel Juliá Serdá,Cristina Cabrera Lacalzada,A. Medina,José Antonio Gullón Blanco,Miguel Ángel García Bello,Pedro Cabrera Navarro +6 more
TL;DR: La prevalencia de EPOC en las Islas Canarias es menor than en the mayoria of las zonas espanolas estudiadas, a pesar of tener una of las tasas de tabaquismo mas altas of Espana.
Journal ArticleDOI
Prevalence of Chronic Obstructive Pulmonary Disease in the Canary Islands
Carlos Cabrera López,Gabriel Juliá Serdá,Cristina Cabrera Lacalzada,A. Medina,José Antonio Gullón Blanco,Miguel Ángel García Bello,Pedro Cabrera Navarro +6 more
TL;DR: Despite having one of the highest rates of smoking in Spain, the prevalence of COPD in the Canary Islands is lower than in most of the Spanish regions studied.
Journal ArticleDOI
Validación pronóstica según los criterios de la GesEPOC 2017
Carlos Cabrera López,Ciro Casanova Macario,José María Marín Trigo,Juan P. de-Torres,Rebeca Sicilia Torres,Jesús María González,Francesca Polverino,Miguel Divo,Victor Pinto Plata,Javier J. Zulueta,Francisco Javier Callejas,Bartolome R. Celli +11 more
TL;DR: La nueva clasificacion de la gravedad de GesEPOC predice la mortalidad de forma adecuada, no obstante, tanto el FEV1% como the disnea tienen la samea potencia para predecir Mortalidad.